Alignment Healthcare, Inc.

ALHC Healthcare Healthcare Plans

Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024. In the quarter to June 2026, revenue grew 31.6%, EPS grew 125.0%, free cash flow fell 229.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

8.30 0.21 +2.60%
Market cap
$1.7B
P/E
39.5×
Fwd P/E
80.3×
Dividend yield
—
F-score
6/9
Altman Z
5.52
Beneish M
−2.73
Dividend safety
n/a
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
— — — 3 4 2 5 6
Altman Z-Score
— — — 4.83 3.81 2.95 3.59 5.52
P/S ratio
— 2.75 2.75 2.07 1.47 0.87 0.79 0.99
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 34.54
Altman Z″-Score (non-manufacturers)
— (2.75) (1.50) 0.09 (1.24) (3.47) (2.32) (0.35)
Beneish M-Score
— — (2.93) (2.79) (2.85) (2.76) (3.30) (2.73)
P/Operating CF
— (259.55) (259.55) (80.23) (14.10) (8.43) (246.40) (77.63)
P/B ratio
— 86.03 86.03 7.90 8.79 10.00 21.26 21.81
EV/Sales
— 2.68 2.68 1.80 1.29 0.78 0.74 0.92
EV/EBITDA
— 207.45 207.45 0.00 0.00 0.00 0.00 79.46
EV/FCF
— (319.41) (319.41) (21.64) (26.81) (14.96) (301.30) 32.07
Current Ratio
— 0.98 1.72 3.31 2.37 1.84 1.88 1.71
Net Debt/EBITDA
— (4.70) (5.10) 1.98 2.27 1.43 1.97 (6.15)
Debt/Equity
— (1.75) 4.71 0.49 0.67 1.02 3.18 1.80
ROE
— 186.00% 95.33% (116.01%) (54.84%) (74.50%) (98.86%) (0.52%)
ROA
— (46.25%) (8.62%) (40.29%) (23.65%) (24.15%) (18.64%) (0.08%)
ROIC
— 0.00% 0.00% 0.00% 0.00% (7,493.96%) 0.00% 0.00%
Return on Tangible Assets
— (182.30%) (16.57%) (46.95%) (42.51%) (54.33%) (33.97%) (0.16%)
Average Days of Receivables
— 17.18 15.27 18.29 23.64 23.97 20.78 23.41
Earnings Yield
— (0.87%) (0.87%) (8.18%) (7.06%) (9.31%) (6.04%) 0.00%
Free Cash Flow Yield
— (0.31%) (0.31%) (4.02%) (3.29%) (6.02%) (0.31%) 2.90%
Free Cash Flow per Share
— (0.01) (0.05) (0.56) (0.38) (0.51) (0.03) 0.57
Book value per Share
— (0.58) 0.20 1.78 1.32 0.85 0.53 0.91
Free Cash Flow
— (1.04) (8.05) (97.14) (69.20) (95.18) (6.63) 113.22
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 246.15
Other line items

Show all line items

Columns are period end dates